Study of Oral OSI-027 in Patients With Advanced Solid Tumors or Lymphoma

NCT00698243 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Any Solid Tumor or Lymphoma

Interventions

DRUG: OSI-027

Sponsor

Astellas Pharma Inc